Caxton Associates LP Karyopharm Therapeutics Inc. Transaction History

Caxton Associates LP

  • $2.65 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 15, 2023
BUY
$2.84 - $3.92 $453,548 - $626,024
159,700 Added 210.34%
235,626 $916,000
Q4 2022

Feb 14, 2023
BUY
$2.48 - $5.93 $9,977 - $23,856
4,023 Added 5.6%
75,926 $258,000
Q3 2022

Nov 14, 2022
BUY
$4.08 - $5.82 $85,312 - $121,696
20,910 Added 41.01%
71,903 $393,000
Q2 2022

Aug 15, 2022
BUY
$4.15 - $8.37 $211,620 - $426,811
50,993 New
50,993 $230,000

Others Institutions Holding KPTI

# of Institutions
98
Shares Held
57.6M
Call Options Held
258K
Put Options Held
81.2K
View Full List

About Karyopharm Therapeutics Inc.

KPTI Quotes by TradingView
  • Ticker KPTI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 79,806,600
  • Market Cap $54.3M
  • Description
  • Karyopharm Therapeutics Inc., a commercial-stage pharmaceutical company, discovers, develops, and commercializes drugs directed against nuclear export for the treatment of cancer and other diseases. The company discovers, develops, and commercializes novel and Selective Inhibitor of Nuclear Export (SINE) compounds function by binding with and in...
More about KPTI
Track This Portfolio

Track Caxton Associates LP Portfolio

Follow Caxton Associates LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Caxton Associates LP, based on Form 13F filings with the SEC.

News

Stay updated on Caxton Associates LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email